A breakthrough revelation has been made by a collaborative study which has paved way for people reeling under the muscle-wasting disease Duchenne muscular dystrophy. The initial symptoms of the disease are seen in boys between the age of 1 and 3 eventually leading them to spend their life till thirties on wheelchair from the age of 12.
Moreover, the drug, SMT C1100, is targeted at quelling the need of a protein called utrophin instead of pricking the problem of dystrophin that’s found in muscle fibers. Apparently, doctors have been recommending steroids and growth hormones in order to manage the dithering health condition.
Apparently, the team of researchers from Oxford University and the University of Bari in Italy has asserted that a single pill instead of any complicated therapy can prove to be beneficial for people under the effect of Duchenne muscular dystrophy.
Responding to the news, Professor Dame Kay Davies of the Department of Physiology, Anatomy and Genetics at Oxford University, who led the research, claimed, “We’ve shown that the drug can dramatically reduce muscle weakness in mice. These results give us everything we need to go forward into initial clinical trials in humans”.
Meanwhile, experts from the Muscular Dystrophy Campaign and the Medical Research Council have reportedly welcomed the effort made by the team.
"Don't allow your disABILITY to shut you out of life; your request for Access has been Granted"
No comments:
Post a Comment